PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment | European Respiratory Society
LAMA - "Long-Acting Muscarinic Antagonists" by AcronymsAndSlang.com
Full article: Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma
inhaled drugs for asthma and COPD | Download Table
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD) - Horita, N - 2017 | Cochrane Library
Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
Long-Acting Muscarinic Antagonists (LAMAs) For Asthma
Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression - Yuji Oba, Nazir A. Lone, 2015
Soft-mist LAMA/LABA combination inhaler launched for COPD | MIMS online
Understanding the role of long-acting muscarinic antagonists in asthma treatment - ScienceDirect
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD | Scientific Reports